Abstract:10.1038/aps.2013.109 S2.1 The anti-fibrotic effect of thymoquinone on thioacetamide-induced mouse hepatic fibrosis Ting BAI, Yong YANG, Li-hua LIAN, Yan-ling WU, Shuang JIANG, Hui-xing ZHENG, Xin LI, Jin-bin LI, You-li YAO, Ji-xing NAN*. Key Laboratory for Natural Resource of Changbai Mountain & Functional Molecules, Ministry of Education, College of Pharmacy, Yanbian University, Yanji 133002, China *To whom correspondence should be addressed. E-mail: jxnanybu@gmail.com Aim: Thymoquinone (TQ) is the main active ingredient from the seeds of Nigella sativa Linn, which has been traditionally used in the Middle East and Southeast Asian countries to treat ailments including asthma, bronchitis, rheumatism, cancer and related inflammatory diseases. In the present study, we investigate the antifibrotic effect and the potential mechanisms of action of TQ against hepatic fibrosis in vivo. Methods: Liver fibrosis was induced by intraperitoneal injections of thioacetamide (TAA, 200 mg/kg) three weekly for 5 weeks in male kunming mice. The administration of TQ (20, 40 mg/kg) was started following TAA injections and was continued for 5 weeks to evaluate the protective effects by hematoxylin and eosin (H&E) staining and Masson staining. The protein and mRNA extracted from liver tissue were analyzed by Western blotting analysis and Real-time Reverse Transcription Polymerase Chain Reaction (RT-PCR). Results: Our data demonstrated that treated with TQ obviously improved tissue damage compared with TAA-only group, in that less inflammatory cell infiltration was observed in H&E and Masson staining results. TQ demonstrated great efficacy in curing hepatic fibrosis via attenuating the TAA-mediated α-smooth muscle actin (α-SMA) and Collagen-I. TQ significantly inhibited the expression of toll-like receptor 4 (TLR4), tissue inhibitor of metalloproteinase-1 (TIMP-1) and α-SMA by Western blotting analysis and RT-PCR. TQ also significantly inhibited phosphatidylinositol 3-kinase (PI3K) phosphorylation and the phosphorylation adenosine monophosphateactivated protein kinase (AMPK) and liver kinase B (LKB)-1. Furthermore, TQ significantly decreased the expression of interleukin (IL)-1b and IL-18 in TAAinduced mouse hepatic fibrosis. Conclusion: The potential anti-fibrosis mechanism of TQ might be associated with the depression of α-SMA and Collagen-I relating with hepatic fibrosis, down-regulating the accompanying inflammatory response in hepatic fibrosis. TQ suppressed PI3K signaling and activated LKB-1 signaling in TAA-induced mouse hepatic fibrosis, suggesting that TQ may be a potential candidate for the therapy of hepatic fibrosis.

Protective role of thymoquinone in hyperlipidemia-induced liver injury in LDL-R −/− mice

Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice

Antioxidant Effects of 2,3-Dihydro-5-hydroxy-4,6-di-tert-butyl-2,2-dipentylbenzofuran and Alpha-Tocopherol in Hyperlipidemic Mice As Evaluated by Hydroxyoctadecadienoic Acid and 7-Hydroxycholesterol

Thymoquinone protected hepatic ischemia reperfusion injury by suppressing oxidative stress

Thymoquinone protects thioacetamide‐induced chronic liver injury by inhibiting TGF‐β1/Smad3 axis in rats

Thymoquinone, a bioactive component of Nigella sativa Linn seeds or traditional spice, attenuates acute hepatic failure and blocks apoptosis via the MAPK signaling pathway in mice

Thymoquinone Alleviates Thioacetamide-Induced Hepatic Fibrosis and Inflammation by Activating Lkb1-Ampk Signaling Pathway in Mice

In Vivo and in Vitro Evaluation of the Anti-inflammatory Effect of Thymoquinone Toward Ischemic Brain Injury Alleviation via Nrf2/HO-1 Pathway

The anti-fibrotic effect of thymoquinone on thioacetamide-induced mouse hepatic fibrosis

Upregulation of SIRT1-AMPK by Thymoquinone in Hepatic Stellate Cells Ameliorates Liver Injury.

Thymoquinone Attenuates Immune Mediated Liver Injury Induced by Concanavalin A in Mice

Thyme (Thymus quinquecostatus Celak) Polyphenol-Rich Extract (TPE) Alleviates HFD-Induced Liver Injury in Mice by Inactivating the TLR4/NF-κB Signaling Pathway through the Gut–Liver Axis

Thymoquinone Attenuates Liver Fibrosis Via PI3K and TLR4 Signaling Pathways in Activated Hepatic Stellate Cells.

Hepato-protective Effect of Thymoquinone Against Acetaminophen-Induced Liver Injury is Linked with Regulation of JNK and AMPK Signaling Pathway

Thymoquinone Prevents and Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice

Thymoquinone Attenuates Acetaminophen Overdose-Induced Acute Liver Injury and Inflammation Via Regulation of JNK and AMPK Signaling Pathway

Anti-fibrotic Effect of Thymoquinone on Hepatic Stellate Cells.

[Protective Effect of Quercetin Against Immunological Liver Injury Through Activating Nrf2/ARE Signaling Pathway].

Thymoquinone attenuates hepatic lipid accumulation by inducing autophagy via AMPK/mTOR/ULK1‐dependent pathway in nonalcoholic fatty liver disease

Design, Synthesis, and Acute Toxicity Assays for Novel Thymoquinone Derivative TQFL12 in Mice and the Mechanism of Resistance to Toxicity

Protective Effects Of Quercetin And Quercetin-5 ',8-Disulfonate Against Carbon Tetrachloride-Caused Oxidative Liver Injury In Mice